Figure 1.

Gain Therapeutics, Inc.

Change in MDS-UPDRS scores from Baseline at Day 150 in all patients for whom CSF GluSph were available, patients with low baseline GluSph, and patients with high baseline GluSph

Format

JPEG

Quelle:

Gain Therapeutics, Inc.

Downloads